Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 14.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 14.0 Contact Hours.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org/
default.jsp?exam-moccme

Qualified by the American Board of Radiology on June 26, 2017 in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program.

>This activity has been qualified by the American Board of Radiology for 1.5 SAM credits.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Celldex Therapeutics Inc., Genentech, Lilly, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Pfizer, and Syndax Pharmaceuticals, Inc..

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

16th Annual International Congress on the Future of Breast Cancer® West

16th Annual International Congress on the Future of Breast Cancer® West


July 14-15, 2017
Marriott Marquis San Diego Marina
San Diego, CA

Overview

The 16th Annual International Congress on the Future of Breast Cancer® West serves as an update on advances in the breast cancer field, with a focus on the clinical implications of breast cancer genetic and phenotypic subtyping. Novel agents, strategies, and improved regimens are changing the future of breast cancer therapy, and these advances and their clinical impact are highlighted throughout the program. Current controversies in the field are also addressed and debated and new data presented, along with information about how to optimally individualize breast cancer therapy. This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from and interact with international leaders in breast cancer in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Celldex Therapeutics Inc., Genentech, Lilly, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Pfizer, and Syndax Pharmaceuticals, Inc..

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. 

Lerning Objectives

  • Determine testing strategies that can be utilized to facilitate the diagnosis, ability to stratify risk, and identification of predictive markers in the care of patients with breast cancer
  • Apply personalized treatment planning to manage patients with breast cancer based on information obtained from testing strategies
  • Delineate approaches that apply local therapies, such as surgical and radiation therapies, to manage patients with breast cancer
  • Describe key evidence concerning the use of evolving strategies for the care of breast cancer
  • Place recent clinical trial findings in the context of evolving treatment paradigms in the field of breast cancer management
  • Identify patients who may benefit from inclusion in a clinical trial evaluating investigational approaches in the setting of breast cancer


Program Co-Chairs

Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX

Sara Hurvitz, MD
Director, Breast Cancer Clinical Research Program
Co- Director, Santa Monica – UCLA Outpatient Hematology/Oncology Practice
Associate Professor of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA Santa Monica, CA






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By